Regulation of Drusen Formation and Degradation in AMD
Principal Investigator
Dennis Clegg, PhD
University of California, Santa Barbara
Santa Barbara, CA, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$50,000
Active Dates
April 01, 2002 - March 31, 2003
Grant ID
M2002053
Summary
One of the hallmarks of age-related macular degeneration (AMD) is the formation of drusen deposits on the basement membrane underlying the retinal pigment epithelium (RPE). The loss of RPE, possibly caused by the presence of drusen, leads to the loss of photoreceptors, or light-sensing cells, and loss of vision. The mechanisms of drusen deposition and degradation are poorly understood. Dr. Clegg has hypothesized that matrix metalloproteinases (MMPs), enzymes that degrade proteins, are involved in the formation and degradation of drusen. It builds on an important observation that Sorsby’s fundus dystrophy, a blinding disease that is similar to AMD, is associated with mutations of the enzyme tissue inhibitor of metalloproteinase-3 (TIMP-3). TIMP-3 is an inhibitor of MMP activity. Dr. Clegg has suggested that accumulation of TIMP-3 leads to inhibition of MMP activity and drusen accumulation. The goal of this study is to examine RPE cells that are in close proximity to Drusen, as well as cells that are in remote areas of the retina not associated with Drusen, and to determine the activity of MMPs and TIMP. The results of these experiments will allow future efforts to develop new treatments for AMD that either lessen drusen accumulation or bring about its removal.
Grants
Related Grants
Macular Degeneration Research
Anti-Drusen Nanobodies for AMD
Active Dates
April 01, 2010 - October 01, 2012
Principal Investigator
Anne Messer, PhD
Anti-Drusen Nanobodies for AMD
Active Dates
April 01, 2010 - October 01, 2012
Principal Investigator
Anne Messer, PhD
Macular Degeneration Research
OA1 Signaling and AMD
Active Dates
April 01, 2010 - May 31, 2012
Principal Investigator
Brian Mckay, PhD
OA1 Signaling and AMD
Active Dates
April 01, 2010 - May 31, 2012
Principal Investigator
Brian Mckay, PhD
Macular Degeneration Research
CCR3 Biology and Imaging Applied to CNV in AMD
Active Dates
April 01, 2010 - June 25, 2012
Principal Investigator
Judit Baffi, MD, PhD
CCR3 Biology and Imaging Applied to CNV in AMD
Active Dates
April 01, 2010 - June 25, 2012
Principal Investigator
Judit Baffi, MD, PhD